Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Orexin receptors, also known as hypocretin receptors, are G protein–coupled receptors (GPCRs) that mediate the physiological effects of the neuropeptides orexin-A and orexin-B. There are two main subtypes: Orexin receptor type 1 (OX1R, HCRTR1) and Orexin receptor type 2 (OX2R, HCRTR2). They play critical roles in regulating arousal, wakefulness, appetite/feeding behavior, and energy homeostasis. OX1R is more involved in reward-seeking behavior and arousal, while OX2R plays a dominant role in sleep-wake regulation. Several antagonists targeting these receptors have been developed for treating sleep disorders such as insomnia. Both receptors activate Gq proteins leading to increased intracellular calcium levels and downstream signaling including activation of ERK pathways.
GPCR activation via orexin-A or orexin-B binding; Gq protein activation, increase of intracellular calcium levels; ERK pathway activation; Antagonists block orexin binding and subsequent activation.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Orexin Receptor Type 1 and Type 2 (OX1R/OX2R).